The FDA has approved a new topical, once-daily lotion for the treatment of acne vulgaris in patients aged 9 years and older.​​​​​​​

The FDA approved adapalene gel 0.1% (Differin Gel), a once-daily, over-the-counter, topical gel for the treatment of acne in people 12 years of age or older.

The FDA Nonprescription Drugs Advisory Committee (NDAC) voted 16-0 on April 15 that adapalene gel 0.1% (Differin Gel), a long-approved prescription topical retinoid for acne is safe for over-the-counter (OTC) use. This recommendation is a first-in-class switch.

Once-daily dapsone Gel, 7.5% (Aczone, Allergan PlC), a new prescription topical treatment for inflammatory and non-inflammatory acne in patients 12 years of age and older, received FDA approval.